Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

November 28, 2022

Renal Recovery in HFCS with Impella 5.5® with SmartAssist®

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5® with SmartAssist®.

November 18, 2022

FDA Fully Approves Impella® Post-approval Studies for Major Indications

Chuck Simonton, MD, announces that Abiomed has successfully completed all Impella post-approval studies for high-risk PCI, cardiogenic shock, post-cardiotomy cardiogenic shock, and right heart failure.

November 16, 2022

Lawrance: Biventricular Support for Myocarditis

Christopher Lawrance, MD, presents the case of an otherwise healthy 35-year-old woman who requires biventricular Impella support for myocarditis.

November 16, 2022

Sandesara: Heart Team Success Story

Pratik Sandesara, MD, presents a complex case requiring escalation to Impella 5.5® with SmartAssist®.

October 5, 2022

REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

October 5, 2022

STEMI DTU™: “Unloading Is Not Delaying Treatment” 

Vijay Iyer, MD, discusses important concepts being explored in the STEMI-DTU™ trial, emphasizing that unloading is not delaying treatment. 

September 30, 2022

Dr. Navin Kapur: Lessons Learned in STEMI DTU™ Pilot Study–TCT 2022

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

September 30, 2022

Dr. Navin Kapur: Cardiogenic Shock Working Group and SCAI Shock Stages–TCT 2022

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

September 30, 2022

Dr. Katherine Kunkel: Best Practices in Cardiogenic Shock–TCT 2022

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022. 

September 29, 2022

Dr. Kate Kearney: Contemporary Techniques for Optimal Outcomes in High-risk PCI–TCT 2022

Kate Kearney, MD, presents a case and discusses contemporary techniques for optimal outcomes in high-risk PCI at TCT 2022. 

September 29, 2022

Live from TCT – September 17, 2022

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day one of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.

September 28, 2022

Live from TCT – September 18, 2022

This recap of highlights from day two of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller and Taishi Hirai.

September 28, 2022

Live from TCT – September 19, 2022

Day three highlights from TCT 2022 include several late-breaking trials and interviews with Navin Kapur, MD, and Koichi Toda, MD, PhD.

September 27, 2022

TCT 2022: OPTIMUM Study Sub-Analysis Results

Adam Salisbury, MD, presents preliminary results from the OPTIMUM Study at TCT 2022.

September 27, 2022

TCT 2022: Influential Trials in High-Risk PCI

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

NPS-1674